Some actions of 4,17a-dimethyl-4,17a-diaza-D-homo-5alpha-androstane dimethiodide (HS-342), a new neuromuscular blocking drug.
D000731:Androstanes / Q000138:chemical synthesis / Q000494:pharmacology*; D000818:Animals; D001372:Aza Compounds / Q000494:pharmacology; D002415:Cats; D002645:Chickens; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D006168:Guinea Pigs; D006718:Homosteroids / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010277:Parasympathomimetics / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D051381:Rats; D012584:Sciatic Nerve / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects / Q000294:innervation
D000731:Androstanes; D001372:Aza Compounds; D002800:Cholinesterase Inhibitors; D006718:Homosteroids; D009467:Neuromuscular Depolarizing Agents; D010277:Parasympathomimetics; D014403:Tubocurarine